Cargando…
Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications
SIMPLE SUMMARY: Head and neck squamous cell carcinomas (HNSCCs) develop from mucosal cells in the oral cavity, pharynx and larynx after either prolonged exposure to tobacco and alcohol, or a transforming infection with high-risk human papillomavirus (HPV). HPV-negative HNSCCs develop in a zone of pr...
Autores principales: | van Harten, Anne M., Brakenhoff, Ruud H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199752/ https://www.ncbi.nlm.nih.gov/pubmed/34204886 http://dx.doi.org/10.3390/cancers13112774 |
Ejemplares similares
-
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death
por: van Harten, Anne M., et al.
Publicado: (2019) -
Potentially novel options for treatment of HPV-attributable head and neck cancer
por: Brakenhoff, Ruud H.
Publicado: (2013) -
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition
por: van Harten, Anne M., et al.
Publicado: (2020) -
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck
por: de Boer, D. Vicky, et al.
Publicado: (2017) -
MERTK as a novel therapeutic target in head and neck cancer
por: von Mässenhausen, Anne, et al.
Publicado: (2016)